Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
PTGX
#1031
Protagonist Therapeutics, Inc
92.080
0
+6.88%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
+6.88%
Monthly Change
+11.68%
6 month change
+22.56%
Cambio anual
+22.56%
Cierres anteriores
86.150
0
Open
92.210
0
Bid
Ask
Low
92.080
0
High
92.220
0
Volumen
152
Markets
Acciones
Atención Sanitaria
PTGX
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
43.81 M
48.41 M
51.28 M
58.27 M
61.38 M
63.81 M
—
Valuation ratios
Enterprise value
765.82 M
1.53 B
427 M
1.18 B
2.27 B
5.44 B
15.61 B
Price to earnings ratio
—
—
-4.15
-16.85
9.13
-42.6
197.31
Price to sales ratio
—
—
19.89
22.16
5.78
120.66
173.34
Price to cash flow ratio
—
—
4.89
18.93
13.64
96.28
256.13
Price to book ratio
—
—
2.45
3.95
3.72
9.03
13.23
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.2
0.36
0.51
0.22
0.37
0.19
0.19
Return on equity %
0.24
0.42
0.59
0.23
0.41
0.21
0.2
Return on invested capital %
881.2
2 568.99
5 504.26
6 840.28
655.36
311.93
459.71
Gross margin %
100
100
100
100
100
100
400
Operating margin %
72.17 K
460.01
494.24
156.09
58.2
343.63
2 488.48
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
73.99 K
458.94
479.26
131.59
63.34
282.83
2 099.78
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
7.84
7.74
7.8
16.71
12.48
12.71
59.98
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0
0.08
0.09
0.2
0.79
0.07
0.06
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.03
—
—
—
—
—
—
Long term debt to total equity ratio
0.04
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
2.2
1.24
2.83
0.91
0.93
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
4.84
6.02
6.44
8.92
36.06
Net current asset value per share
—
—
4.96
6.26
9.09
9.09
37.39
Tangible book value per share
—
—
4.4
5.93
10.38
9.67
41.25
Working capital per share
—
—
4.32
5.89
8.36
8.37
34.85
Book value per share
—
—
4.4
5.93
10.38
9.67
41.25
Noticias
Protagonist Therapeutics no alcanza por 0,35$ las previsiones de BPA en el cuarto trimestre del año
Protagonist Therapeutics earnings missed by $0.35, revenue fell short of estimates
Citizens eleva el precio objetivo de Protagonist Therapeutics por aprobaciones de fármacos
Citizens eleva precio objetivo de Protagonist Therapeutics por aprobaciones
Citizens raises Protagonist Therapeutics stock price target on drug approvals
Director de Protagonist Therapeutics Williams vende acciones por 1,48 millones de dólares
Director de Protagonist Therapeutics vende acciones por $1.48 millones
Protagonist Therapeutics director Williams sells $1.48 million in shares
Director de Protagonist Therapeutics vende acciones por 1,67 millones de dólares
Director de Protagonist Therapeutics vende acciones por $1.67 millones
Protagonist Therapeutics director sells $1.67 million in shares
Las principales acciones biotecnológicas a seguir en 2026, según Truist